Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zithromax and Cefazolin for Prevention of Febrile Morbidity After Emergency C-Section
NCT05647993Completed
- Sponsor
- Ministry of Public Health
- Start
- Dec 2022
- Primary completion
- Nov 2023
- Countries
- 1
01
Overview
Randomised, double-blind trial in Postoperative fever (POF) comparing Control group (Placebo) with azithromycin (2 arms). Primary endpoint: Incidence of Febrile Morbidity. Started Dec 2022; status: completed.
02
Drugs
azithromycin
03
Conditions
Postoperative fever (POF)
Beyond the preview
Go deeper on NCT05647993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05647993.